These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Effects of various treatments of bovine complement on its lytic efficacy measured by two different tests. Nielsen K, Rosenbaum B, Ballinger R, Stiller J. Vet Immunol Immunopathol; 1984 Jul; 6(3-4):273-83. PubMed ID: 6385462 [Abstract] [Full Text] [Related]
27. Activation of the alternative and classical complement pathways by Entamoeba histolytica. Calderon J, Schreiber RD. Infect Immun; 1985 Nov; 50(2):560-5. PubMed ID: 2865212 [Abstract] [Full Text] [Related]
28. Haemolysis of human erythrocytes heavily sensitized with sheep amboceptor by sheep complement chelated with EGTA or Mg2+-EGTA. Stankiewicz M, Jonas W. Vet Immunol Immunopathol; 1981 Jun; 2(3):253-64. PubMed ID: 6178207 [Abstract] [Full Text] [Related]
30. In vitro inhibition of the classical and alternate pathways of activation of human complement by N acetyl aspartyl glutamic acid (NAAGA). Etievant M, Leluc B, David B. Agents Actions; 1988 Jun; 24(1-2):137-44. PubMed ID: 3261498 [Abstract] [Full Text] [Related]
31. Screening for deficiencies in the classical and alternative pathways of complement by hemolysis in gel. Truedsson L, Sjöholm AG, Laurell AB. Acta Pathol Microbiol Scand C; 1981 Jun; 89(3):161-6. PubMed ID: 7032205 [Abstract] [Full Text] [Related]
32. Complement-inhibiting and anti-inflammatory properties of chlorazole fast pink 2BL. Doherty NS. Clin Exp Immunol; 1981 Feb; 43(2):260-9. PubMed ID: 7273480 [Abstract] [Full Text] [Related]
34. In vitro inhibition of the classical pathway of human complement by polymyxin B. Asghar SS, Boot T, van der Helm HJ. Biochem Pharmacol; 1987 Sep 15; 36(18):2927-30. PubMed ID: 2820426 [Abstract] [Full Text] [Related]
35. Surface-associated heparin inhibits zymosan-induced activation of the human alternative complement pathway by augmenting the regulatory action of the control proteins on particle-bound C3b. Kazatchkine MD, Fearon DT, Silbert JE, Austen KF. J Exp Med; 1979 Nov 01; 150(5):1202-15. PubMed ID: 501288 [Abstract] [Full Text] [Related]
37. Inhibition of complement by a series of substituted 2-aryl-1,3-indandiones: interaction with the fifth component of complement. Asghar SS, Siddiqui AH, van der Goot H, Timmerman H. Mol Immunol; 1986 May 01; 23(5):459-65. PubMed ID: 3748011 [Abstract] [Full Text] [Related]
38. Effect of a streptococcal preparation on the complement system. Kato H, Yokoe N, Matsumura N, Nishida K, Ikezaki M, Hosokawa K, Hotta T, Takemura S, Yoshikawa T, Kondo M. Jpn J Exp Med; 1979 Oct 01; 49(5):343-50. PubMed ID: 529490 [Abstract] [Full Text] [Related]
39. Activation of the alternative complement pathway by blood culture isolates of Bacteroides fragilis. Joiner KA, Hawiger A, Gelfand JA. Infect Immun; 1981 Oct 01; 34(1):303-5. PubMed ID: 6795126 [Abstract] [Full Text] [Related]
40. Inhibition of the classical and alternative pathways of the human complement system by glycosaminoglycan polysulfate. de Messias IT, Mohren D, Kajdacsy-Balla A. J Investig Allergol Clin Immunol; 1994 Oct 01; 4(4):172-6. PubMed ID: 7850029 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]